Brazil · Findings · Debarred / sanctioned abroad × US SEC issuer
BMY · SUB · BR · FUNDO ESTADUAL DE SAUDE
Why it is here
Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «BRISTOL-MYERS SQUIBB FARMACEUTICA LTDA (+ more 1 legal entities of the family)» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 8 non-competitive contracts at the buyer «FUNDO ESTADUAL DE SAUDE», 31,468,721 BRL (≈ $5,664,370); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modalidadeId: 9; modalidadeNome: Inexigibilidade; modoDisputaId: 5; modoDis; OCID ocds-ye9ov3-4384829000196_2025_411, ocds-ye9ov3-733062000102_2025_24, ocds-ye9ov3-733062000102_2025_25, ocds-ye9ov3-733062000102_2026_1; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb); ↓ weak method (catalogue / exclusivity / accreditation / small purchase); class B: direct method prescribed by law (loan, lease, inter-agency) or pandemic emergency purchase.
Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.
Details
- Company / subject
- BMY · SUB · BR · FUNDO ESTADUAL DE SAUDE
- Indicator
- Debarred / sanctioned abroad × US SEC issuer
- Amount
- 5,664,370
- Records behind the indicator
- 8
- Found
- 4 October 2026
- Code
- W-00160
- Reference
- ocds-ye9ov3-4384829000196_2025_411
- Reference
- ocds-ye9ov3-733062000102_2025_24
- Reference
- ocds-ye9ov3-733062000102_2025_25
- Reference
- ocds-ye9ov3-733062000102_2026_1
- Reference
- 2015-10-05